Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation

References

• BeerAMAdlerMLeitfaden Naturheilverfahren: für die ärztliche PraxisGuide to Natural Remedies: for Medical Practice1st edMunichElsevier2011 German
   Google Scholar
• BeerAMKuhlemannHKranzhoffMNaturheilverfahren und konventionelle Medizin bei ausgewählten Magen-Darm-ErkrankungenNaturopathic and conventional medicine in selected gastrointestinal disordersNaturaMed20001561826 German
   Google Scholar
• NeoptolemosJPMooreMJCoxTFEffect of adjuvant chemotherapy with flurouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adnocarcinoma: the ESPAC-3 periampullary cancer randomized trialJAMA2012308214715622782416
   PubMed Web of Science ®Google Scholar
• WegenerTWagnerHThe active components and the pharmacological multi-target principle of STW 5 (Iberogast)Phytomedicine200613Suppl 5203516926095
   PubMed Web of Science ®Google Scholar
• KrollUCordesCPharmaceutical prerequisites for a multi-target therapyPhytomedicine200613Suppl 5121916857355
   PubMed Web of Science ®Google Scholar
• PilichiewiczANHorowitzMRussoAEffects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy menAm J Gastroenterol200710261276128317378904
   PubMed Web of Science ®Google Scholar
• MadischAMelderisHMayrGSassinIHotzJEin Phytotherapeutikum und seine modifizierte Rezeptur bei funktioneller Dyspepsie. Ergebnisse einer doppelblinden plazebokontrollierten VergleichsstudieA plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative studyZ Gastroenterol2001397511517 German11505331
   PubMed Web of Science ®Google Scholar
• SibaevAYueceBKelberOSTW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of micePhytomedicine200613Suppl 5808916713219
   PubMed Web of Science ®Google Scholar
• MüllerMHLiuCYGlatzleJSTW 5 (Iberogast) reduces afferent sensitivity in the rat small intestinePhytomedicine200613Suppl 510010616713220
   PubMed Web of Science ®Google Scholar
• KhayyalMTSeif-El-NasrMEl-GhazalyMAOkpanyiSNKelberOWeiserDMechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidityPhytomedicine200613Suppl 5566616963243
   PubMed Web of Science ®Google Scholar
• MichaelSAbdel-AzizHWeiserDMüllerCEKelberONieberKAdenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparationsNaunyn Schmiedebergs Arch Pharmacol2011385441142122160002
   PubMed Web of Science ®Google Scholar
• MichaelSKelberOHauschildtSSpanel-BorowskiKNieberKInhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6Phytomedicine2009162–316117119196500
   PubMed Web of Science ®Google Scholar
• SchemppHWeiserDKelberOElstnerEFRadical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its componentsPhytomedicine200613Suppl 5364416777393
   PubMed Web of Science ®Google Scholar
• GermannIHagelauerDKelberOAntioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast)Phytomedicine200613Suppl 5455016713223
   PubMed Web of Science ®Google Scholar
• SchemppHHippeliSWeiserDKelberOElstnerEFComparison of the inhibition of myeloperoxidase-catalyzed hypochlorite formation in vitro and in whole blood by different plant extracts contained in a phytopharmacon treating functional dyspepsiaArzneimittelforschung200454738939515344843
   PubMed Web of Science ®Google Scholar
• KruegerDGruberLBuhnerSThe multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestineNeurogastroenterol Motil200921111203e11019210628
   PubMed Web of Science ®Google Scholar
• AmmonHPKelberOOkpanyiSNSpasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth musclePhytomedicine200613Suppl 5677416978852
   PubMed Web of Science ®Google Scholar
• HeinleHHagelauerDPaschtUKelberOWeiserDIntestinal spasmolytic effects of STW 5 (Iberogast) and its componentsPhytomedicine200613Suppl 5757916709451
   PubMed Web of Science ®Google Scholar
• HohenesterBRühlAKelberOSchemannMThe herbal preparation STW5 (lberogast) has potent and region-specific effects on gastric motilityNeurogastroenterol Motil200416676577315601427
   PubMed Web of Science ®Google Scholar
• SallerRPfister-HotzGItenFMelzerJReichlingJIberogast(r): Eine moderne phytotherapeutische Arzneimittelkombination zur Behandlung funktioneller Erkrankungen des Magen-Darm-Trakts (Dyspepsie, Colon irritabile) – von der Pflanzenheilkunde zur “Evidence Based Phytotherapy”. Eine systematische ÜbersichtIberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome) – from phytomedicine to “evidence based phytotherapy.” A systematic reviewForsch Komplementarmed Klass Naturheilkd20029Suppl 1120 German12618546
   PubMedGoogle Scholar
• RöschWLiebregtsTGundermannKJVinsonBHoltmannGPhytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5Phytomedicine200613Suppl 511412116978851
   PubMed Web of Science ®Google Scholar
• RaedschRHanischJBockPSibaevAVinsonBGundermannKJWirksamkeit und Unbedenklichkeit des Phytopharmakons STW 5 versus Metoclopramid bei funktioneller Dyspepsie unter Praxisbedingungen – eine retrolektive KohortenstudieAssessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia – a retrolective cohort studyZ Gastroenterol2007451010411048 German17924300
   PubMed Web of Science ®Google Scholar
• RöschWVinsonBSassinIVergleich der Wirksamkeit des pflanzlichen Therapeutikums STW 5 mit dem Prokinetikum Cisaprid bei Patienten mit funktioneller Dyspepsie des Dysmotilitätstyps. Eine randomisierte klinische StudieA randomized clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsiaZ Gastroenterol2002406401408 German12055663
   PubMed Web of Science ®Google Scholar
• AllescherHDWagnerHSTW 5/Iberogast: Multi-Target-Wirkung bei funktioneller Dyspepsie und ReizdarmsyndromSTW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndromeWien Med Wochenschr200715713–14301307 German17704976
   PubMedGoogle Scholar
• von ArnimUPeitzUVinsonBGundermannKJMalfertheinerPSTW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind studyAm J Gastroenterol20071021061268127517531013
   PubMed Web of Science ®Google Scholar
• MadischAHoltmannGPleinKHotzJTreatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-center trialAliment Pharmacol Ther200419327127914984373
   PubMed Web of Science ®Google Scholar
• MalfertheinerPHoltmannGPeitzUTeilnehmer der Leitlinien- Konferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur Behandlung der DyspepsieGuidelines of the German Society of Digestive and Metabolic Diseases for treatment of dyspepsiaZ Gastroenterol20013911937956 German11778153
   PubMed Web of Science ®Google Scholar
• WrightTHYazbeckRLymnKAThe herbal extract, Iberogast, improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositisCancer Biol Ther200981092392919276679
   PubMed Web of Science ®Google Scholar
• MacLeanNHübner-SteinerUBehandlung arzneimittelbedingter Magen-Darm-Beschwerden. Doppelblindstudie zur Wirksamkeit von Iberogast im Vergleich zu PlazeboTreatment of drug-induced gastrointestinal disorders. Double-blind study of the effectiveness of Iberogast compared to placeboFortschr Med198710512239242 German3297957
   PubMedGoogle Scholar